Ann: Investor Conference Call, page-57

"I can't help wondering if there were flaws in the preliminary studies design that led to over estimation of accuracy."

There are two key differences between the studies:

1. Australian study using the inventor to evaluate the results.

2. US study using double blind trials with three of the best hospitals in the world.

RAP want us to believe that study 1 was kosher, and study 2 was mishandled.

Hmmmmmm.